Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001365101 | SCV001561344 | uncertain significance | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | 2021-12-13 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with PSTPIP1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 1056295). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln179*) in the PSTPIP1 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in PSTPIP1 cause disease. |